AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.8% | 3,771 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 3,771 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 3,771 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 3,771 | +101.5% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 1,871 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 1,871 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | +600.0% | 1,871 | +353.0% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 413 | +61.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 256 | -39.5% | 0.00% | – |
| Q1 2020 | $3,000 | – | 423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
| Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
| Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
| Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
| Ergoteles LLC | 849,000 | $300,000 | 0.01% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |